Ebola drug Remdesivir shows no positive impact on Covid-19 patients: Lancet study

The Lancet's study shows that Remdesivir, the drug used for the treatment of Ebola virus, has not shown any positive results on COVID-19 patients.
Market Update
SENSEX 31,622.48 -187.07(%)
NIFTY 9,898.00 -54.2(%)

Top News